Yue Zhao, MS

Bristol Myers Squibb

Yue Zhao is currently an Associate Director in the Department of Clinical Pharmacology and Pharmacometrics at Bristol Myers Squibb. She earned her MS in Pharmacometrics from University of Maryland, and MS in Analytical Chemistry from University of Utah. She has over 10 years of experiences of drug development across various stages in pharmaceutical industry. Her current main research is focused on the development and implementation of the model-informed drug development (MIDD) strategy for drugs and other therapeutic agents in clinical development. She has contributed throughout the scientific community and published both original research and review papers and has presented her research at national meetings.

Poster(s):

• P-208 - EXPOSURE RESPONSE ANALYSES OF NIVOLUMAB AS ADJUVANT TREATMENT FOR PATIENTS WITH ESOPHAGEAL OR GASTROESOPHAGEAL JUNCTION CANCER (CHECKMATE 577).

• P-209 - MODEL-INFORMED CLINICAL PHARMACOLOGY (CP) PROFILE OF A NOVEL FIXED-DOSE COMBINATION (FDC) OF RELATLIMAB AND NIVOLUMAB IN PATIENTS WITH SOLID TUMORS.